Olympus offers the Trans Urethral Resection in saline (TURis) for theAlpha O.R.-a new bipolar procedure with multiple applications made to workwith the complete line of Olympus resectoscopes.
Neoadjuvant chemo confers greater odds of pCR in upper tract urothelial carcinoma
The investigators reported that pCR was significantly higher in the neoadjuvant chemotherapy + RNU group vs RNU alone, with an OR of 2.49 (95% CI: 1.75 – 3.54, P < .001).
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
Hormone therapy does not increase radium-223 OS benefit in mCRPC
Concomitant abiraterone or enzalutamide did not boost the radium-223 survival benefit in patients with bone-dominant metastatic castration-resistant prostate cancer.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Trial of 64Cu/67Cu SAR-bisPSMA progresses following positive data
No dose-limiting toxicities were observed among the initial 3 patients in cohort 3, and no patients experienced adverse events related to 64Cu-SAR-bisPSMA.
177Lu-PSMA-617 tolerable in patients with mCRPC and baseline cytopenias
"However, these patients have an overall poor prognosis,” noted Mohamed E. Ahmed, MD.
2 Clarke Drive Cranbury, NJ 08512